Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Communication Strategies. Case Studies. Applied Knowledge.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.
Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including Twitter, LinkedIn and Facebook.
Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact email@example.com.
Posted 21 February 2023 | By RAPS
Salma Michor, the new chair of the RAPS Europe Board of Directors, outlines some of the priorities for her term.
Posted 30 January 2023 | By Nicole Duran
Posted 16 January 2023 | By Nicole Duran
RAPS launched a networking group in India that already features 377 discussion posts.
Posted 12 January 2023 | By Ryan Connors
Passing an RAC exam is no easy feat. Kudos to these professionals for their achievement.
Posted 14 December 2022 | By Nicole Duran
The RAPS Board of Directors named Interim Executive Director Bill McMoil Executive Director on Wednesday.
Posted 09 May 2022 | By Ariana Pelosci
Investigators identified that in pivotal clinical trials supporting FDA approvals of CAR T-cell therapies for patients with hematologic cancer, Black patients were significantly underrepresented.
Posted 06 May 2022
Stakeholders in a session at MedCon 2022 expressed largely positive sentiments about their experience with the US Food and Drug Administration’s (FDA) Digital Health Software Precertification (Pre-Cert) Program.
Posted 05 May 2022 | By Shawn M. Schmitt
The draft document from the US agency looks to officially recognize a program aimed at advancing quality in medical devices and their manufacturing.
Posted 12 April 2022 | By Alan Condon
The FDA has issued two guidelines that make it less complex for medtech companies to commercialize orthopedic devices and sutures using its safety and performance-based pathway, according to the Regulatory Affairs Professionals Society.